Jeffrey Vacirca, MD, FACP, is a renowned cancer physician and visionary leader with extensive experience and commitment to community oncology.

Dr. Vacirca assumed the role of CEO and Chairman of the Board of New York Cancer & Blood Specialists (NYCBS) in 2008 when he helped salvage the previous practice from bankruptcy by the existing shareholders. As a result, after two years, the practice emerged as a stronger unified group of physicians dedicated to reinventing themselves as the premier cancer care deliverers of New York.

Dr. Vacirca has led NYCBS through an unparalleled period of transformation and incredible growth to grow into the leading oncology practice that now sees nearly a million patients a year throughout more than 30 oncology locations and 35 hospital affiliations.

Dr. Vacirca takes action against key billings, including abuse of pharmacy benefit managers (PBMs) and sequester cuts. He formed the Conquering Cancer PAC, which advocates for cancer patients and, most importantly, strives to ensure access and availability for all patients no matter where they live.

Dr. Vacirca is the medical director for the International Oncology Network, part of AmerisourceBergen, and has been part of their contracting advisory board for almost 15 years. Additionally, he has served as President of the Community Oncology Alliance and continues to be a member of their executive committee. Dr. Vacirca also serves on the board of directors of Spectrum Pharmaceuticals, OneOncology, BeyondSpring, and the American Red Cross of Greater New York. Most of his roles in these remarkable companies focus on legislative advocacy for the cost of cancer care and access.

Dr. Vacirca is the immediate past president of the Community Oncology Alliance (COA), medical director for the International Oncology Network, part of AmerisourceBergen, a Scientific Advisory Board Member for Caris Life Sciences, president and co-founder of National Translational Research Group, and serves as a medical board advisor for Flatiron Health. He has been part of early funding for some remarkable companies, including Cedar, Thyme Care, and Sherpa Health. Dr. Vacirca co-founded Odonate Therapeutics in 2016.

Subsequently, he serves on the board of directors of Annexus Health, Spectrum Pharmaceuticals, and BeyondSpring. In addition, he is the medical director for the International Oncology Network (ION), Oncology Network Development at Mt. Sinai Health Network, and Long Island Aids Care (LIAC). In addition, Dr. Vacirca is the founder and Chairman of the Board of Directors of the New York Cancer Foundation, which provides financial assistance to patients undergoing treatment for cancer.

Dr. Vacirca was honored as Humanitarian of the Year by the American Red Cross, a recipient of the Theodore Roosevelt Award for outstanding dedication to patient care, and named Newsday’s Top Doctors. He was also honored for his role in enabling the Long Island Association for AIDS Care staff to bring state-of-the-art HIV testing to New York.